The global clinical trials market is anticipated to grow at a CAGR of 6-7% from 2024 to 2029. This growth is driven by the ...
1d
Week99er on MSNWhy IRT Clinical Trial Companies Rely on RTSM for Seamless StudiesClinical trials are essential in bringing innovative treatments to the market, but managing them efficiently requires cutting-edge technology. This is where IRT clinical trial companies play a crucial ...
1d
GlobalData on MSNWHO releases Lancet papers that delve further into clinical trial guidanceThe Lancet research papers build on the WHO’s Guidance for best practices in clinical trials released in September 2024.
11d
Pharmaceutical Technology on MSNEuropean agencies catch up with speedier regulatory pathways for CGTs in the USShorter trial authorisation timelines for ATMP trials in the US are an advantage for biotechs, say experts. Although the ...
While China has become a key country for global clinical trials, navigating regulatory complexities and ensuring data ...
Clinical research agreements (CRAs) and developing a regulatory strategy—particularly in connection with the Food and Drug Administration ...
Investigators should be aware that studies that meet the definition of clinical trial may be subject to additional regulatory and/or policy requirements, such as posting of consent forms on federal ...
The company's objective was to assess the essential documentation for submission, determine the necessity of conducting ...
regional and country-specific regulatory and privacy requirements and clinical trial guidelines regarding participant data confidentiality. These are all critical consideration for sponsors ...
The HFpEF Summit is a biannual, two-day meeting bringing together internationally recognized leaders in the clinical, biological, and translational study of HFpEF. This summit focused on the latest ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results